posit danicopan pnh updat initi expect earli
continu recommend share follow top-line data disclos today
achn danicopan oral factor inhibitor combin soliri pnh patient
manag note pnh patient experi clinic
extravascular hemolysi caus anemia depend on-going blood
transfus treatment number pnh patient continu experi
form anemia measur hemoglobin level hb g/dl thu
rational combin two therapi make sens us view today
updat yet anoth support data point hypothesi achn acquisit
expect close like setup move forward continu broaden
diversifi portfolio remain buyer
posit danicopan updat morn achn announc top-line data
studi evalu danicopan oral factor inhibitor combin soliri
pnh patient inadequ respons monotherapi recal
interim updat patient reach week averag
hemoglobin hb increas g/dl baselin result today full set
patient consist averag hb increas g/dl find
impress follow combo treatment patient receiv blood transfus
unit given month period prior screen patient
receiv transfus unit beyond improv also note
number addit paramet includ reduct bilirubin reticulocyt
well improv qualiti life measur safeti treatment gener
well toler though two patient experienc sae resolv
patient complet studi
catalyst move toward expect close achn acquisit
today updat bode well futur potenti combo danicopan soliris/ultomiri
pnh patient achn confirm today theyv held meet
regul begin trial earli detail disclos yet trial
design regul feedback continu wait close transact
addit clinic detail layer opportun model
remain buyer like alxn continu progress broaden diversifi
portfolio believ today updat support valid bd
strategi acquir achn continu like setup remain buyer
alexion develop market therapi address rare diseas
discount back
associ market pipelin product
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
rate price target histori inc
creat bluematrix
note box rate price target histori chart indic date fundament equiti research note rate price
target box repres date analyst made chang rate price target except first box may repres
first note written past three year
distribut ratings/ib servic
note distribut ratings/ib servic show number compani current cover fundament equiti research rate categori
piper jaffray affili receiv compens invest bank servic within past month finra rule requir disclosur
